Vertex Pharmaceuticals ( VRTX 5.31%) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 days. On Dec. 20, 2024, the FDA gave a thumbs-up to Alyftrek in treating cystic ...

Caprock Group LLC boosted its stake in shares of FedEx Co. (NYSE:FDX – Free Report) by 19.1% in the fourth quarter, according ...

Short FDX slightly under 265.57, target n/a, stop loss @ 266.34 Check the time stamp on this data. Updated AI-Generated ...

The U.S. Food and Drug Administration (FDA) approved suzetrigine under the brand name Journavx on Jan. 30, 2025. Journavx is a first-in-class non-opioid painkiller that acts on sodium channels in the ...

We recently compiled a list of the 10 Large-Cap Stocks Insiders Are Buying Recently. In this article, we are going to take a look at where FedEx Corporation (NYSE:FDX) stands against the other ...

Independence Bank of Kentucky grew its stake in shares of FedEx Co. (NYSE:FDX – Free Report) by 520.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities ...

Shares of FedEx Corp. FDX slid 1.62% to $264.87 Friday, on what proved to be an all-around poor trading session for the stock ...

Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.

Journavx is the first and only approved non-opioid oral painkiller and the first new class of pain medicine approved in more ...

JPMorgan lowered the firm’s price target on UPS (UPS) to $120 from $135 and keeps a Neutral rating on the shares post the Q4 report. The ...

Stifel analysts adjusted their outlook on UPS (NYSE:UPS) by reducing the price target to $145, down from the previous $153, while continuing to endorse the stock with a Buy rating. The revision ...

FedEx stock is trading lower on Thursday in sympathy with United Postal Service, which fell after it reported 2024 ...